PermeaDerm

PermeaDerm is a medical technology company specializing in the development of advanced biosynthetic skin substitutes for wound management. The company's core technology features a transparent, flexible, and permeable matrix that allows for the controlled passage of fluid and the application of topical medications without removing the dressing. Its product portfolio, including PermeaDerm B and PermeaDerm C, is designed to treat complex wounds such as partial-thickness burns, chronic ulcers, and donor sites. The technology was developed by Dr. Aubrey Woodroof, a pioneer in the field who previously created the Biobrane skin substitute. In August 2024, the company was acquired by Mölnlycke Health Care to enhance their global portfolio of wound care solutions. PermeaDerm's products are FDA-cleared and utilized in burn centers and hospitals worldwide.